000
| 01296nam 2200301za 4500 |
---|
001 | 9.696297 |
---|
003 | CaOODSP |
---|
005 | 20231123084324 |
---|
007 | cr ||||||||||| |
---|
008 | 150407|2012||||xxc|||||o f|0| 0 eng d |
---|
020 | |a978-1-100-20861-9 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aFR5-38/4-2012E-PDF |
---|
110 | 1 |aCanada.|bForeign Affairs and International Trade Canada. |
---|
245 | 10|aInvest in Canada - biopharmaceuticals, 2012 |h[electronic resource] |
---|
246 | 3 |aBiopharmaceuticals - Canada's Competitive Advantages |
---|
260 | |aOttawa - Ontario : |bForeign Affairs and International Trade |cFall 2012. |
---|
300 | |a12p.|bcoloured figs. |
---|
520 | 3 |aShowcases Canada as a location of choice for foreign direct investment. |
---|
590 | |a13-32|b2013-08-09 |
---|
690 | 07|aInvestment policy|2gcpds |
---|
690 | 07|aPharmaceutical industry|2gcpds |
---|
775 | 08|tInvestir au Canada - produits biopharmaceutiques, 2012 |w(CaOODSP)9.640415 |
---|
776 | 0#|tInvest in Canada - biopharmaceuticals, 2012 |w(CaOODSP)9.652560 |
---|
794 | |tInvest in Canada : |w(CaOODSP)9.698723 |
---|
795 | |tInvest in Canada - biopharmaceuticals |w9.694494 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s1.28 MB|uhttps://publications.gc.ca/collections/collection_2013/aecic-faitc/FR5-38-4-2012-eng.pdf |
---|